(Q33852582)

29 July 2017

Anticoagulant heparan sulfate precursor structures in F9 embryonal carcinoma cells (English)

1 reference

29 July 2017

1 reference

1 reference

1 reference

Zhang L

1

1 reference

29 July 2017

Yoshida K

series ordinal

2

1 reference

29 July 2017

Liu J

series ordinal

3

1 reference

29 July 2017

Rosenberg RD

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

Journal of Biological Chemistry

29 July 2017

1 reference

29 July 2017

274

1 reference

29 July 2017

9

1 reference

29 July 2017

5681-5691

1 reference

Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor

29 July 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Evaluation of critical groups required for the binding of heparin to antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Sequence variation in heparin octasaccharides with high affinity for antithrombin III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Characterization of specific receptors for vasopressin in the pituitary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Low-sulphated oligosaccharides derived from heparan sulphate inhibit normal angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Role of endothelial cell surface heparin-like polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Identification and expression in mouse of two heparan sulfate glucosaminyl N-deacetylase/N-sulfotransferase genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-O-sulfotransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Expression of the mouse mastocytoma glucosaminyl N-deacetylase/ N-sulfotransferase in human kidney 293 cells results in increased N-sulfation of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

The disaccharide composition of heparins and heparan sulfates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Contribution of monosaccharide residues in heparin binding to antithrombin III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Evidence for degradation of heparan sulfate by endoglycosidases: Glucosamine and hexuronic acid are reducing terminals of intracellular heparan sulfate from human skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Lysolecithin-induced alteration of subendothelial heparan sulfate proteoglycans increases monocyte binding to matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Turnover of heparan sulfate depends on 2-O-sulfation of uronic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Substrate specificity of heparanases from human hepatoma and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Patterns of sulphation in heparan sulphate: polymorphism based on a common structural theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Biosynthesis of heparin and heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Cell mutants defective in synthesizing a heparan sulfate proteoglycan with regions of defined monosaccharide sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Sulphated and undersulphated heparan sulphate proteoglycans in a Chinese hamster ovary cell mutant defective in N-sulphotransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Domain structure of heparan sulfates from bovine organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Molecular organization of heparan sulphate from human skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Age-dependent modulation of heparan sulfate structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

The putative heparin-specific N-acetylglucosaminyl N-Deacetylase/N-sulfotransferase also occurs in non-heparin-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

The retinoic acid and cAMP-dependent up-regulation of 3-O-sulfotransferase-1 leads to a dramatic augmentation of anticoagulantly active heparan sulfate biosynthesis in F9 embryonal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

Characterization of a platelet endoglycosidase degrading heparin-like polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.9.5681

21 January 2018

Identifiers

DOI

10.1074/JBC.274.9.5681

1 reference

29 July 2017

1 reference